| Title: |
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial |
| Authors: |
Dearnaley, David a, b, *; Syndikus, Isabel c; Mossop, Helen a; Khoo, Vincent a, b; Birtle, Alison d; Bloomfield, David e; Graham, John f; Kirkbride, Peter g; Logue, John h; Malik, Zafar c; Money-Kyrle, Julian i; O'Sullivan, Joe M j; Panades, Miguel k; Parker, Chris a, b; Patterson, Helen l, †; Scrase, Christopher m; Staffurth, John n; Stockdale, Andrew o; Tremlett, Jean e; Bidmead, Margaret b; Mayles, Helen c; Naismith, Olivia b; South, Chris i; Gao, Annie a, b; Cruickshank, Clare a; Hassan, Shama a; Pugh, Julia a; Griffin, Clare a; Hall, Emma a |
| Source: |
In The Lancet Oncology August 2016 17(8):1047-1060 |
| Database: |
ScienceDirect |